Work

A randomized phase II trial comparing two doses of lenalidomide for the treatment of stage IV ocular melanoma

Year: 2009

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2009.27.15_suppl.e20012

Authors: J. B. Zeldis, C. Heller, G. Seidel, N. Yuldasheva, D. Stirling, Y. Shutack, S. K. Libutti

Institutions: National Cancer Institute, Celgene (United States)

Language: English

Topic: Ocular Oncology and Treatments

Subfield: Ophthalmology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2963597051

Cites:

Cited by: 6

Related to: 10